Clinical Trial Update: Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of neratinib in older patients with stage IV HER2-positive breast cancer has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• neratinib (neratinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: HER2 Positive Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 | Phase 2 | Status: COMPLETED | Results posted: 2022-03-16